Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

10526

1

SERVOTRONICS INC /DE/ Servotronics Reports 7.3% Revenue Growth, Net Loss Narrows in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10527

1

LanzaTech Global, Inc. LanzaTech Global Reports 49% Revenue Decline, Net Loss Increase in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10528

1

GRAHAM CORP Graham Corporation Reports 19% Revenue Growth, Net Income Surge in Q2 Fiscal 2025

Via official filing (AI summary) | 6 months ago | 0 comments

10529

1

Smart Powerr Corp. Smart Powerr Corp. Reports Net Loss, Increased Expenses, and Cash Reserves Amid Strategic Shift to Energy Storage Solutions

Via official filing (AI summary) | 6 months ago | 0 comments

10530

1

GraniteShares Gold Trust GraniteShares Gold Trust Reports 12.77% Net Asset Value Increase, Cost of Investment in Gold Bullion Decreases

Via official filing (AI summary) | 6 months ago | 0 comments

10531

1

Uniti Group Inc. Uniti Group Reports Significant Financial Improvements in Q3 2024, Net Income Surges to $12.2 Million

Via official filing (AI summary) | 6 months ago | 0 comments

10532

1

CORPAY, INC. Corpay Reports 6% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10533

1

Pulmatrix, Inc. Pulmatrix Reports Decreased Revenue, Improved Losses in Q3 2024, Seeks Additional Funding

Via official filing (AI summary) | 6 months ago | 0 comments

10534

1

GraniteShares Platinum Trust GraniteShares Platinum Trust Reports Decline in Net Assets and Platinum Value in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10535

1

MYRIAD GENETICS INC Myriad Genetics Reports 11% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10536

1

COHEN & STEERS, INC. Cohen & Steers Reports 7.7% Revenue Growth, 23.5% Net Income Increase in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10537

1

CLOVER HEALTH INVESTMENTS, CORP. /DE Clover Health Reports 8.2% Revenue Growth, Improved Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10538

1

ANI PHARMACEUTICALS INC ANI Pharmaceuticals Reports 12.5% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10539

1

Monopar Therapeutics Monopar Therapeutics Reports Continued Losses, Strategic Developments Amid Ongoing Clinical Trials

Via official filing (AI summary) | 6 months ago | 0 comments

10540

1

XPEL, Inc. XPEL Reports 9.9% Revenue Growth and Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10541

1

SANDY SPRING BANCORP INC Sandy Spring Bancorp Reports Mixed Q3 Results Amid Changing Market Conditions

Via official filing (AI summary) | 6 months ago | 0 comments

10542

1

LANTRONIX INC Lantronix Reports 4.2% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10543

1

Holley Inc. Holley Inc. Reports Challenging Financial Performance for 13 and 39 Weeks Ended September 29, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10544

1

RB GLOBAL INC. RB Global Inc. Reports 4% Revenue Decline, 20% Net Income Growth in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10545

1

Canopy Growth Corp Canopy Growth Reports 9% Revenue Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10546

2

Datadog, Inc. Datadog Reports 26% Revenue Growth to $690M in Q3 2024, Net Income Turnaround

Via official filing (AI summary) | 6 months ago | 0 comments

10547

1

PROSPECT CAPITAL CORP Prospect Capital Reports Decline in Revenue and Net Asset Value, Strategic Portfolio Adjustments

Via official filing (AI summary) | 6 months ago | 0 comments

10548

1

International Money Express, Inc. International Money Express Reports Mixed Q3 Results, Net Income Growth Amid Revenue Fluctuations

Via official filing (AI summary) | 6 months ago | 0 comments

10549

1

Akero Therapeutics, Inc. Akero Therapeutics Reports 88% Year-Over-Year Net Loss Increase, Raises $344.8 Million in Follow-On Public Offering

Via official filing (AI summary) | 6 months ago | 0 comments

10550

1

Y-mAbs Therapeutics, Inc. Y-mAbs Therapeutics Reports Decline in Revenues and Increased Net Losses for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments